Food Safety Hosting international research on antimicrobial resistance

by Editor fleischwirtschaft.com
Wednesday, November 21, 2018
Photo: Danish Agriculture & Food Council FmbA
Related Topics:

Denmark AMR


Denmark took an important first step in the process of strengthening global governance in the fight against antimicrobial resistance (AMR) when Danish Minister of Health Ellen Trane Nørby signed a memorandum of understanding with the Consultative Group on International Agricultural Research (CGIAR).

The agreement states mutual intentions to collaborate closely on the establishing an independent research centre, the International Centre for Interdisciplinary Solutions on AMR, in Denmark.

“Antimicrobial resistance is a serious global threat that requires ambitious global solutions on multiple levels. I am very proud that Denmark is now taking leadership in our future global work on finding new solutions for the serious challenges with antimicrobial resistance we are facing today.” says Danish Minister of Health, Ellen Trane Nørby.

“Denmark is globally recognized for our work with antimicrobial resistance. I would be very pleased to have the new AMR-centre placed in Denmark. This will give Denmark an opportunity to remain in the lead, when it comes to world class research in antimicrobial resistance and attract top scientists across to world to Denmark.” says Danish Minister for Environment and Food Jakob Elleman-Jensen.

The World Bank has discussed the need for strengthened global governance in the fight against AMR with the Danish government for approximately a year.

The ambition of the future International Centre for Interdisciplinary Solutions on AMR is that the Centre serves as an independent knowledge node for evidence and research on AMR. To fulfil the ambition support from international organizations, countries and other partners is crucial. The imperative of the centre is also to support the development and implementation of context-specific solutions for AMR-elimination with a particular focus on low- and middle-income countries as the prevalence of drug resistant generally is higher in these countries than in most industrialized countries.

 

stats